643 related articles for article (PubMed ID: 15857016)
41. Human papillomavirus vaccines versus cervical cancer screening.
Stanley M
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):388-94. PubMed ID: 18538554
[TBL] [Abstract][Full Text] [Related]
42. The use of vaccines in the prevention and treatment of cervical cancer.
Davidson EJ; Kitchener HC; Stern PL
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):193-200. PubMed ID: 12109821
[TBL] [Abstract][Full Text] [Related]
43. Chapter 16: Prophylactic human papillomavirus vaccines.
Lowy DR; Frazer IH
J Natl Cancer Inst Monogr; 2003; (31):111-6. PubMed ID: 12807954
[TBL] [Abstract][Full Text] [Related]
44. Papillomavirus-like particle vaccines for cervical cancer.
Schiller JT
Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
[TBL] [Abstract][Full Text] [Related]
45. Prophylactic HPV vaccination: past, present, and future.
Castle PE; Maza M
Epidemiol Infect; 2016 Feb; 144(3):449-68. PubMed ID: 26429676
[TBL] [Abstract][Full Text] [Related]
46. Recent progress in vaccination against human papillomavirus-mediated cervical cancer.
McKee SJ; Bergot AS; Leggatt GR
Rev Med Virol; 2015 Mar; 25 Suppl 1():54-71. PubMed ID: 25752816
[TBL] [Abstract][Full Text] [Related]
47. Papillomavirus vaccines in clinical trials.
Galloway DA
Lancet Infect Dis; 2003 Aug; 3(8):469-75. PubMed ID: 12901889
[TBL] [Abstract][Full Text] [Related]
48. Prevention of cervical cancer through papillomavirus vaccination.
Frazer IH
Nat Rev Immunol; 2004 Jan; 4(1):46-54. PubMed ID: 14704767
[TBL] [Abstract][Full Text] [Related]
49. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319
[TBL] [Abstract][Full Text] [Related]
50. Preventative and therapeutic vaccines for cervical cancer.
Roden R; Wu TC
Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
52. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?
Saleem A; Tristram A; Fiander A; Hibbitts S
Minerva Med; 2009 Dec; 100(6):503-23. PubMed ID: 20010484
[TBL] [Abstract][Full Text] [Related]
53. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
55. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
56. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases.
Villa LL
Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583
[TBL] [Abstract][Full Text] [Related]
57. Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening.
Sherman ME; Schiffman MH; Strickler H; Hildesheim A
Diagn Cytopathol; 1998 Jan; 18(1):5-9. PubMed ID: 9451552
[TBL] [Abstract][Full Text] [Related]
58. [Biology of the papillomavirus infections: V. Vaccine developments].
Seilles E; Riethmuller D; Mougin C
Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
[TBL] [Abstract][Full Text] [Related]
59. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
Khaliq SA; Shyum Naqvi SB; Fatima A
Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
[TBL] [Abstract][Full Text] [Related]
60. [Human papillomavirus: a vaccine against cervical carcinoma uterine].
Franceschi S
Epidemiol Prev; 2002; 26(3):140-4. PubMed ID: 12197051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
